Merck & › Financials
Merck & financials
MRKTen years from Merck &’s own SEC filings. Fiscal years end in December.
Income statement
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Jun 2026 | Latest quarterJun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $39.81B | $40.12B | $42.29B | $39.12B | $41.52B | $48.70B | $59.28B | $60.12B | $64.17B | $65.01B | $66.57B | — |
| Net income | $3.92B | $2.39B | $6.22B | $9.84B | $7.07B | $13.05B | $14.52B | $365.0M | $17.12B | $18.25B | $3.17B | — |
| Earnings per share, diluted | $1.41 | $0.87 | $2.32 | $3.81 | $2.78 | $5.14 | $5.71 | $0.14 | $6.74 | $7.28 | — | — |
Balance sheet
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Jun 2026 | Latest quarterJun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $6.51B | $6.09B | $7.96B | $9.68B | $8.06B | $8.10B | $12.69B | $6.84B | $13.24B | $14.56B | — | $6.85B |
| Total assets | $95.38B | $87.87B | $82.64B | $84.40B | $91.59B | $105.69B | $109.16B | $106.67B | $117.11B | $136.87B | — | $129.80B |
| Debt | $24.80B | $24.40B | $25.10B | $26.30B | $31.80B | $33.10B | $30.70B | $35.10B | $37.10B | $49.30B | — | $53.90B |
| Total liabilities | $55.07B | $53.30B | $55.76B | $58.40B | $66.18B | $67.44B | $63.10B | $69.04B | $70.73B | $84.20B | — | $87.82B |
| Shareholders' equity | $40.09B | $34.34B | $26.70B | $25.91B | $25.32B | $38.18B | $45.99B | $37.58B | $46.31B | $52.61B | — | $41.93B |
Cash flow
| Dec 2016fiscal year | Dec 2017fiscal year | Dec 2018fiscal year | Dec 2019fiscal year | Dec 2020fiscal year | Dec 2021fiscal year | Dec 2022fiscal year | Dec 2023fiscal year | Dec 2024fiscal year | Dec 2025fiscal year | Last 12 monthsto Jun 2026 | Latest quarterJun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $10.38B | $6.45B | $10.92B | $13.44B | $10.25B | $13.12B | $19.09B | $13.01B | $21.47B | $16.47B | $19.97B | — |
| Capital spending | $1.61B | $1.89B | $2.62B | $3.37B | $4.43B | $4.45B | $4.39B | $3.86B | $3.37B | $4.11B | $3.90B | — |
| Free cash flow | $8.76B | $4.56B | $8.31B | $10.07B | $5.82B | $8.67B | $14.71B | $9.14B | $18.10B | $12.36B | $16.06B | — |
| Buybacks | $3.43B | $4.01B | $9.09B | $4.78B | $1.28B | $840.0M | $0 | $1.35B | $1.31B | $5.08B | $4.21B | — |
| Dividends | $5.12B | $5.17B | $5.17B | $5.70B | $6.21B | $6.61B | $7.01B | $7.45B | $7.84B | $8.18B | $8.30B | — |
| Returned to shareholders | $8.56B | $9.18B | $14.26B | $10.47B | $7.50B | $7.45B | $7.01B | $8.79B | $9.15B | $13.26B | $12.50B | — |
| Stock-based pay | $300.0M | $312.0M | $348.0M | $388.0M | $441.0M | $479.0M | $541.0M | $645.0M | $761.0M | $820.0M | $892.0M | — |
Where these numbers come from
Every column links to the filing it comes from on EDGAR. Last 12 months adds the latest year to date to the last 10-K and takes away the same months a year earlier. Debt is long-term debt including the part due within a year. A dash means the company did not report that line in a form we can read, never a zero. Market cap uses the latest closing price and the share count from the cover of the latest filing. How we count
Merck & financials, answered
What is Merck &'s market cap?
$360.08B at $145.95 a share, with 2,467,171,638 shares outstanding as of Jul 31, 2026, from the cover of its latest SEC filing.
How much does Merck & earn?
Revenue of $66.57B and net income of $3.17B in the last 12 months to Jun 2026.
How much debt does Merck & have?
Merck & reported $53.90B of debt and $6.85B of cash and equivalents on its balance sheet in Jun 2026.
Does Merck & make free cash flow?
Yes. Operating cash flow minus capital spending was $16.06B in the last 12 months to Jun 2026.
How much cash does Merck & return to shareholders?
$13.26B in buybacks and dividends in fiscal 2025, from the cash flow statement.